10 mg Peptide Strength
Each vial contains a labeled strength of 10 mg of MOTS-C.
Mitochondrial-Derived Peptide
Dragon Pharma Peptide Product
Dragon Pharma MOTS-C is supplied as a lyophilized powder in a 2 mL vial and contains the mitochondrial-derived peptide MOTS-C at a labeled strength of 10 mg. Product specifications, storage information, and available payment options are provided below.
Each vial contains a labeled strength of 10 mg of MOTS-C.
Supplied as a freeze-dried powder that requires reconstitution with bacteriostatic water before use.
Packaged in a standard 2 mL peptide vial with a rubber stopper and aluminum seal.
MOTS-C is a mitochondrial-derived peptide that has been investigated in preclinical research for its potential effects on metabolism and cellular energy regulation.
| Product name | MOTS-C 10 mg |
|---|---|
| Active substance | MOTS-C |
| Labeled strength | 10 mg/vial |
| Container | 2 mL vial |
| Total labeled content | 10 mg per vial |
| Product form | Lyophilized powder |
| Manufacturer | Dragon Pharma |
Other peptide options from the same product line include SS-31 50 mg, another mitochondrial-targeted peptide, and AICAR 50 mg, a compound investigated for metabolic research. These products differ in their peptide structure and research applications.
Science & Research
MOTS-C is a mitochondrial-derived peptide encoded by the mitochondrial genome. It has been investigated in preclinical research for its potential effects on metabolism, insulin sensitivity, and cellular energy regulation. This section provides a brief overview of what is known about this peptide from research literature.
MOTS-C is a peptide encoded by the mitochondrial genome, specifically within the 12S rRNA region. It is one of several mitochondrial-derived peptides that have been identified in recent years.
Preclinical research has investigated MOTS-C for its potential effects on metabolic processes, including glucose metabolism, insulin sensitivity, and cellular energy homeostasis.
MOTS-C has been studied in research settings for its potential effects on metabolism and related physiological processes. The peptide has been investigated for its interactions with cellular pathways involved in energy regulation.
This product is supplied as a lyophilized powder and must be reconstituted with bacteriostatic water or sterile water for injection before use. The addition of water converts the freeze-dried powder into a solution suitable for research applications.
The reconstituted peptide solution should be stored as recommended on the product label. Peptide solutions are typically refrigerated and used within a specified timeframe after reconstitution to maintain integrity.
Peer-reviewed research on MOTS-C is available through the National Institutes of Health and other scientific databases. The following link provides general information on this peptide and its mechanism of action.
Important Health Information
Peptide research compounds such as MOTS-C have limited clinical safety data. The information below is derived from published preclinical research and general knowledge of peptide biology and does not constitute medical advice.
MOTS-C has not been extensively studied in humans. The available safety information comes primarily from preclinical research.
The full range of metabolic effects of MOTS-C, including its potential influence on glucose metabolism and insulin sensitivity, is not fully characterized in a clinical context.
Subcutaneous injection carries risks including injection-site reactions, infection and improper technique. Sterile handling and correct reconstitution procedures are essential.
The potential systemic effects of MOTS-C and its interactions with other physiological systems are not fully understood.
This peptide research compound should not be used by individuals with known allergies or sensitivities to peptide compounds, or by those who are pregnant, nursing or have active malignancies.
The long-term effects and safety profile of MOTS-C have not been established in any population. Research on this peptide is still in the early stages.
Medical advice is particularly important for individuals with diabetes or glucose metabolism disorders, cardiovascular disease, cancer or a history of cancer, or those taking medications that affect metabolism or mitochondrial function. This peptide should not be used during pregnancy or breastfeeding.
The product should also be stored securely to prevent accidental access or use by children or other household members, particularly after reconstitution when it contains a liquid solution.
MOTS-C is not specifically listed on the World Anti-Doping Agency Prohibited List at the time of writing. Athletes should check the current list before competition, as prohibited substances are subject to change. Some peptide compounds may fall under general prohibitions on substances with similar biological effects.
The current status and applicable rules can be checked through the World Anti-Doping Agency Prohibited List.
Common Product Questions
Quick answers about MOTS-C 10 mg specifications, storage, shipping, Bitcoin payment and general product information.
Dragon Pharma MOTS-C 10 mg is a lyophilized peptide product containing 10 mg of the mitochondrial-derived peptide MOTS-C per vial. It is supplied in a 2 mL vial for research purposes.
MOTS-C is a mitochondrial-derived peptide encoded by the mitochondrial genome. It has been investigated in preclinical research for its potential effects on metabolism, insulin sensitivity, and cellular energy regulation.
Each vial contains a labeled strength of 10 mg of MOTS-C.
The product is supplied as a lyophilized powder in a 2 mL vial. It requires reconstitution with bacteriostatic water or sterile water for injection before use.
Store the lyophilized powder in its original packaging at room temperature or refrigerated, protected from excessive heat, moisture and direct light. Once reconstituted, peptide solutions typically require refrigeration and should be used within a limited timeframe. Always follow the specific storage directions printed on the product label.
Lyophilized peptide powders are generally stable at room temperature but should be protected from heat. After reconstitution, peptide solutions typically require refrigeration. Check the product label for specific storage instructions.
Delivery depends on the warehouse selected for the order. Shipments from the USA Warehouse typically take 4–5 business days after dispatch, while shipments from the International Warehouse typically take 15–20 business days after dispatch. Full delivery and reship information is available on the Shipping Information page.
Yes. Bitcoin and other supported cryptocurrencies are available at checkout for all orders. To buy MOTS-C 10 mg with Bitcoin, select Bitcoin as the payment method during checkout and follow the payment instructions provided with the order.
Bitcoin transactions are recorded on a public blockchain and should not be considered automatically anonymous. Accurate order and delivery information is still required for order processing and shipping.
MOTS-C is not specifically listed on the World Anti-Doping Agency Prohibited List at the time of writing. Athletes should check the current list before competition, as prohibited substances are subject to change.
Additional research on this peptide is available through the National Institutes of Health and other scientific databases. A direct link to PubMed references is provided in the Science & Research section above.